Sichuan Yiasuo Pharmaceutical Technology

Sichuan Yiasuo Pharmaceutical Technology is a China-based biotechnology company specializing in the discovery and development of innovative small molecule drugs, with a primary focus on protein degradation technologies. The company leverages its proprietary molecular glue and PROTAC platforms to target "undruggable" proteins involved in cancer and immunological diseases. Yiasuo's lead programs are designed to address unmet medical needs in oncology, particularly in hematological malignancies and solid tumors. Headquartered in Chengdu's Tianfu International Bio-Town, the company is backed by prominent venture capital firms and led by a team of experts in medicinal chemistry and drug discovery.